Pluribus Labs’s Steelcase SCS Stock Holding History

Pluribus Labs’s Portfolio SCS Stock Details SCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,747	Closed	-$173K	–	196
2021 Q4	$173K	Buy	+14,747	New	+$178K	0.18%	220

Other funds holding SCS

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Pluribus Labs's SCS Position: Q1 2022 in Review

Pluribus Labs sold out of Steelcase (SCS) in Q1 2022, closing a stake of 14,747 shares — an estimated $173K sold.

Pluribus Labs first reported a position in SCS in Q4 2021 and held it in 1 quarter. The position peaked at $173K in Q4 2021. 199 funds tracked by Wall St. Rank hold SCS as of Q1 2022.

Pluribus Labs reported no remaining Steelcase position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 14,747 Steelcase shares in Q1 2022, an estimated $173K.
Pluribus Labs first reported a position in Steelcase in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Steelcase position peaked at $173K in Q4 2021.
199 funds tracked by Wall St. Rank held Steelcase as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.